宏強控股(08262.HK)及金寧簽訂合作協議
格隆匯12月14日丨宏強控股(08262.HK)發佈公告,於2020年12月11日,公司全資附屬公司明凱投資有限公司及金寧發展有限公司就中國廣西壯族自治區南寧市的潛在項目簽訂了合作協議。
根據合作協議,金寧同意協助明凱在南寧市成立分支公司,並協助明凱在南寧市發展業務。明凱獨家委託金寧介紹及發展在南寧市的投資項目。
金寧是在香港註冊成立的公司,是廣西壯族自治區國有企業南寧市威寧投資集團有限責任公司的全資子公司。金寧的主要業務是商品進出口、金融投資及介紹投資者投資至南寧市。
金寧與南寧市的多家優秀公司有着密切的聯繫。在合作協議下,集團預料將會有多個投資項目會介紹到集團作考慮。董事會認為這是集團在該地區開拓新業務的好機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.